May 21, 2020
May 21, 2020 —
…cares for women with high-risk pregnancies, ramped up quickly for the shift to telehealth. Like cardiologists, Ballas said in-person visits with a mother-to-be allows for better evaluation of their well-being and for measuring the fetal heartbeat. His team conducts new patient visits in-person to understand the patient’s risk and to…
July 1, 2021
July 1, 2021 —
After a nationwide search, Cynthia Gyamfi-Bannerman, MD, has been named chair of the Department of Obstetrics, Gynecology & Reproductive Sciences at University of California San Diego School of Medicine and UC San Diego Health.
September 17, 2020
September 17, 2020 —
…to do to reduce risk of infection or, possibly, co-infection (a simultaneous infection of COVID-19 and the flu). Most immediately, that means getting this year’s flu vaccination. “There isn’t a vaccine for COVID-19,” said Dr. Davey Smith, a translational research virologist and head of the Division of Infectious Diseases and…
May 21, 2015
May 21, 2015 —
…of birth within a highly modern, technologically-advanced medical facility that includes a specialized neonatal intensive care unit. “Jacobs Medical Center is part of the university’s investment in the future of health care for the entire region, and it will advance our goal of enriching human life and society,” said UC…
July 26, 2021
July 26, 2021 —
UC San Diego Health, the region’s only academic health system, is ranked #1 in San Diego and #5 in California, placing it among the nation’s best hospitals, according to the 2021-2022 U.S. News & World Report survey. UC San Diego Health was ranked in the top 50 in 10 specialties.
June 7, 2018
June 7, 2018 —
…in pregnant women during pregnancy and after giving birth. “PMADs can affect women in low-income families and households at almost double the rate,” says co-founder Niranjanaa Jeeva ’19. “That was something that was just unacceptable.” Hapty Hearts co-founders Niranjanaa Jeeva ’19, Ella Stimson ’19 and Julie Yip ’18 display their…
May 26, 2017
May 26, 2017 —
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in…